MET
Price
$78.37
Change
+$0.13 (+0.17%)
Updated
Jul 10 closing price
Capitalization
53.28B
26 days until earnings call
PUK
Price
$25.03
Change
+$0.25 (+1.01%)
Updated
Jul 10 closing price
Capitalization
25.79B
Interact to see
Advertisement

MET vs PUK

Header iconMET vs PUK Comparison
Open Charts MET vs PUKBanner chart's image
MetLife
Price$78.37
Change+$0.13 (+0.17%)
Volume$2.79M
Capitalization53.28B
Prudential
Price$25.03
Change+$0.25 (+1.01%)
Volume$786.61K
Capitalization25.79B
MET vs PUK Comparison Chart in %
Loading...
MET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PUK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MET vs. PUK commentary
Jul 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MET is a StrongBuy and PUK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 11, 2025
Stock price -- (MET: $78.37 vs. PUK: $25.03)
Brand notoriety: MET: Notable vs. PUK: Not notable
Both companies represent the Life/Health Insurance industry
Current volume relative to the 65-day Moving Average: MET: 104% vs. PUK: 86%
Market capitalization -- MET: $53.28B vs. PUK: $25.79B
MET [@Life/Health Insurance] is valued at $53.28B. PUK’s [@Life/Health Insurance] market capitalization is $25.79B. The market cap for tickers in the [@Life/Health Insurance] industry ranges from $133.31B to $0. The average market capitalization across the [@Life/Health Insurance] industry is $24.96B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MET’s FA Score shows that 1 FA rating(s) are green whilePUK’s FA Score has 0 green FA rating(s).

  • MET’s FA Score: 1 green, 4 red.
  • PUK’s FA Score: 0 green, 5 red.
According to our system of comparison, MET is a better buy in the long-term than PUK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MET’s TA Score shows that 4 TA indicator(s) are bullish while PUK’s TA Score has 2 bullish TA indicator(s).

  • MET’s TA Score: 4 bullish, 4 bearish.
  • PUK’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, MET is a better buy in the short-term than PUK.

Price Growth

MET (@Life/Health Insurance) experienced а -2.83% price change this week, while PUK (@Life/Health Insurance) price change was +0.60% for the same time period.

The average weekly price growth across all stocks in the @Life/Health Insurance industry was +1.64%. For the same industry, the average monthly price growth was +5.15%, and the average quarterly price growth was +14.88%.

Reported Earning Dates

MET is expected to report earnings on Oct 29, 2025.

PUK is expected to report earnings on Mar 26, 2025.

Industries' Descriptions

@Life/Health Insurance (+1.64% weekly)

Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MET($53.3B) has a higher market cap than PUK($25.8B). MET has higher P/E ratio than PUK: MET (40.71) vs PUK (15.34). PUK YTD gains are higher at: 59.395 vs. MET (-2.961). PUK has less debt than MET: PUK (4.87B) vs MET (18.8B). MET has higher revenues than PUK: MET (66.4B) vs PUK (12B).
METPUKMET / PUK
Capitalization53.3B25.8B207%
EBITDAN/AN/A-
Gain YTD-2.96159.395-5%
P/E Ratio40.7115.34265%
Revenue66.4B12B553%
Total Cash308BN/A-
Total Debt18.8B4.87B386%
FUNDAMENTALS RATINGS
MET vs PUK: Fundamental Ratings
MET
PUK
OUTLOOK RATING
1..100
1762
VALUATION
overvalued / fair valued / undervalued
1..100
44
Fair valued
81
Overvalued
PROFIT vs RISK RATING
1..100
21100
SMR RATING
1..100
9994
PRICE GROWTH RATING
1..100
5440
P/E GROWTH RATING
1..100
9462
SEASONALITY SCORE
1..100
43n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MET's Valuation (44) in the Life Or Health Insurance industry is somewhat better than the same rating for PUK (81) in the Multi Line Insurance industry. This means that MET’s stock grew somewhat faster than PUK’s over the last 12 months.

MET's Profit vs Risk Rating (21) in the Life Or Health Insurance industry is significantly better than the same rating for PUK (100) in the Multi Line Insurance industry. This means that MET’s stock grew significantly faster than PUK’s over the last 12 months.

PUK's SMR Rating (94) in the Multi Line Insurance industry is in the same range as MET (99) in the Life Or Health Insurance industry. This means that PUK’s stock grew similarly to MET’s over the last 12 months.

PUK's Price Growth Rating (40) in the Multi Line Insurance industry is in the same range as MET (54) in the Life Or Health Insurance industry. This means that PUK’s stock grew similarly to MET’s over the last 12 months.

PUK's P/E Growth Rating (62) in the Multi Line Insurance industry is in the same range as MET (94) in the Life Or Health Insurance industry. This means that PUK’s stock grew similarly to MET’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
METPUK
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
50%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
65%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 1 day ago
67%
Bearish Trend 1 day ago
82%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
57%
Bullish Trend 1 day ago
57%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
49%
Bullish Trend 1 day ago
55%
Advances
ODDS (%)
Bullish Trend 10 days ago
66%
Bullish Trend 15 days ago
60%
Declines
ODDS (%)
Bearish Trend about 1 month ago
53%
Bearish Trend 9 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
73%
Bearish Trend 1 day ago
71%
Aroon
ODDS (%)
Bullish Trend 1 day ago
59%
Bullish Trend 1 day ago
59%
View a ticker or compare two or three
Interact to see
Advertisement
MET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PUK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PALL104.903.65
+3.60%
abrdn Physical Palladium Shares ETF
IVOO108.310.59
+0.55%
Vanguard S&P Mid-Cap 400 ETF
TDSC24.420.07
+0.27%
ETC Cabana Target Drawdown 10 ETF
FDRV15.470.04
+0.24%
Fidelity Elctrc Vhcls & Ftr Trnsptn ETF
CVNY43.33-0.77
-1.75%
YieldMax CVNA Option Income Strategy ETF